Clinical Trial Update: Phase I Study of PollenVax in Patients With Mugwort Pollen-Induced Allergic Rhinitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating PollenVax for mugwort pollen-induced allergic rhinitis; the study is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• PollenVax

Snippet

Sponsor: Kazakh National Agrarian University | Conditions: Allergic Rhinitis Due to Artemisia Pollen | Phase 1 | Status: ACTIVE_NOT_RECRUITING